These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38250345)

  • 1. Structural Optimization and Biological Evaluation of Isoxazolo[5,4
    Strašek Benedik N; Dolšak A; Švajger U; Sosič I; Gobec S; Sova M
    ACS Omega; 2024 Jan; 9(2):2362-2382. PubMed ID: 38250345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Toll-like receptor 7 agonists with novel chromeno[3,4-d]imidazol-4(1H)-one and 2-(trifluoromethyl)quinoline/ quinazoline-4-amine scaffolds.
    Dolšak A; Švajger U; Lešnik S; Konc J; Gobec S; Sova M
    Eur J Med Chem; 2019 Oct; 179():109-122. PubMed ID: 31247373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of quinazoline and pyrrolo[3,2-
    Song Y; Fan W; Yao C; Wang H; Lu X; Wang Y; Liu P; Ma Y; Zhang Z; Wang J; Chu B; Shi L; Yang G; Wang M
    Org Biomol Chem; 2024 Apr; 22(14):2764-2773. PubMed ID: 38497199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dysfunctional innate immune response triggered by Toll-like receptor activation is restored by TLR7/TLR8 and TLR9 ligands in cutaneous lichen planus.
    Domingues R; de Carvalho GC; da Silva Oliveira LM; Futata Taniguchi E; Zimbres JM; Aoki V; da Silva Duarte AJ; Sato MN
    Br J Dermatol; 2015 Jan; 172(1):48-55. PubMed ID: 24976336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor (TLR) 2-9 agonists-induced cytokines and chemokines: I. Comparison with T cell receptor-induced responses.
    Ghosh TK; Mickelson DJ; Fink J; Solberg JC; Inglefield JR; Hook D; Gupta SK; Gibson S; Alkan SS
    Cell Immunol; 2006 Sep; 243(1):48-57. PubMed ID: 17250816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances on Small-Molecule Antagonists Targeting TLR7.
    Zheng H; Wu P; Bonnet PA
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 4, Toll-like receptor 7 and Toll-like receptor 9 agonists enhance immune responses against blood-stage Plasmodium chabaudi infection in BALB/c mice.
    Gao W; Sun X; Li D; Sun L; He Y; Wei H; Jin F; Cao Y
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107096. PubMed ID: 33091818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugation of a Small-Molecule TLR7 Agonist to Silica Nanoshells Enhances Adjuvant Activity.
    Huang CH; Mendez N; Echeagaray OH; Weeks J; Wang J; Vallez CN; Gude N; Trogler WC; Carson DA; Hayashi T; Kummel AC
    ACS Appl Mater Interfaces; 2019 Jul; 11(30):26637-26647. PubMed ID: 31276378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor agonists partially restore the production of pro-inflammatory cytokines and type I interferon in Sézary syndrome.
    Manfrere KC; Torrealba MP; Miyashiro DR; Oliveira LM; de Carvalho GC; Lima JF; Branco AC; Pereira NZ; Pereira J; Sanches JA; Sato MN
    Oncotarget; 2016 Nov; 7(46):74592-74601. PubMed ID: 27780938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further hit optimization of 6-(trifluoromethyl)pyrimidin-2-amine based TLR8 modulators: Synthesis, biological evaluation and structure-activity relationships.
    Dolšak A; Šribar D; Scheffler A; Grabowski M; Švajger U; Gobec S; Holze J; Weindl G; Wolber G; Sova M
    Eur J Med Chem; 2021 Dec; 225():113809. PubMed ID: 34488023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Small Molecule Dual Inhibitors Targeting Toll-Like Receptors
    Padilla-Salinas R; Anderson R; Sakaniwa K; Zhang S; Nordeen P; Lu C; Shimizu T; Yin H
    J Med Chem; 2019 Nov; 62(22):10221-10244. PubMed ID: 31687820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
    Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
    J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.
    Wang X; Chen Y; Zhang S; Deng JN
    PLoS One; 2022; 17(4):e0260565. PubMed ID: 35452465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR7/TLR8 Activation Restores Defective Cytokine Secretion by Myeloid Dendritic Cells but Not by Plasmacytoid Dendritic Cells in HIV-Infected Pregnant Women and Newborns.
    Cardoso EC; Pereira NZ; Mitsunari GE; Oliveira LM; Ruocco RM; Francisco RP; Zugaib M; da Silva Duarte AJ; Sato MN
    PLoS One; 2013; 8(6):e67036. PubMed ID: 23826189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR agonist mediated suppression of allergic responses is associated with increased innate inflammation in the airways.
    Duechs MJ; Hahn C; Benediktus E; Werner-Klein M; Braun A; Hoymann HG; Gantner F; Erb KJ
    Pulm Pharmacol Ther; 2011 Apr; 24(2):203-14. PubMed ID: 21195789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accessory-cell-mediated activation of porcine NK cells by toll-like receptor 7 (TLR7) and TLR8 agonists.
    Toka FN; Nfon CK; Dawson H; Golde WT
    Clin Vaccine Immunol; 2009 Jun; 16(6):866-78. PubMed ID: 19369481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-tumor Activity of Toll-Like Receptor 7 Agonists.
    Chi H; Li C; Zhao FS; Zhang L; Ng TB; Jin G; Sha O
    Front Pharmacol; 2017; 8():304. PubMed ID: 28620298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of High-Potency Human TLR8 and Dual TLR7/TLR8 Agonists in Pyrimidine-2,4-diamines.
    Beesu M; Salyer AC; Brush MJ; Trautman KL; Hill JK; David SA
    J Med Chem; 2017 Mar; 60(5):2084-2098. PubMed ID: 28146629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics.
    Huang X; Zhang X; Lu M
    Expert Opin Drug Discov; 2021 Aug; 16(8):869-880. PubMed ID: 33678093
    [No Abstract]   [Full Text] [Related]  

  • 20. Design and Synthesis of Polyphenolic Imidazo[4,5-
    Kumar K; Sihag B; Patil MT; Singh R; Sakala IG; Honda-Okubo Y; Singh KN; Petrovsky N; Salunke DB
    ACS Pharmacol Transl Sci; 2024 Jul; 7(7):2063-2079. PubMed ID: 39022355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.